B Field

Author PubWeight™ 31.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Provision of sex education and early sexual experience: the relation examined. BMJ 1995 2.21
2 Properties of pyruvate dehydrogenase of rat mammary tissue and its changes during pregnancy, lactation and weaning. Biochem J 1974 1.19
3 Letter: Aetiology of anencephaly and spina bifida. Br Med J 1976 1.18
4 Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum 1990 1.08
5 Season and interval for recurrence of neural tube defects. J Med Genet 1981 1.07
6 Control of rat mammary-gland pyruvate dehydrogenase by insulin and prolactin. Biochem J 1976 1.06
7 Letter: Antenatal diagnosis of neural-tube defects. Lancet 1975 0.98
8 The role of chronic constipation, diarrhea, and laxative use in the etiology of large-bowel cancer. Data from the Melbourne Colorectal Cancer Study. Dis Colon Rectum 1988 0.98
9 Some international trends in the incidence of neural tube defects. Community Health Stud 1983 0.96
10 Human fibroblast conditioned media contains growth-promoting activities for low density cells. J Cell Physiol 1977 0.94
11 Neural tube defects in New South Wales, Australia. J Med Genet 1978 0.91
12 Diet, alcohol, smoking, serum beta-carotene, and vitamin A in male nonmelanocytic skin cancer patients and controls. Nutr Cancer 1992 0.90
13 Effects of prolactin withdrawal on activity of pyruvate dehydrogenase of rat mammary gland. Biochem Soc Trans 1975 0.90
14 Antiinflammatory activity of a Ghanaian antiarthritic herbal preparation: III. J Ethnopharmacol 1995 0.90
15 Incidence of neural-tube defects. Dev Med Child Neurol 1982 0.90
16 Dietary and alcohol intake, smoking pattern, occupational risk, and family history in lung cancer patients: results of a case-control study in males. Nutr Cancer 1989 0.88
17 A supportive-expressive group intervention for women with a family history of breast cancer: results of a phase II study. Psychooncology 2000 0.87
18 Letter: Twinning and neural-tube defects. Lancet 1974 0.86
19 Inhibition of hepatic drug metabolism by norethindrone. Clin Pharmacol Ther 1979 0.85
20 Sexual behaviour in young people. Baillieres Clin Obstet Gynaecol 1996 0.84
21 Letter: Ovulation stimulation and defects of neural-tube closure. Lancet 1974 0.84
22 Potato blight and neural-tube defects. Lancet 1973 0.84
23 The child with an encephalocele. Med J Aust 1974 0.83
24 Oral and pharyngeal cancer, diet, smoking, alcohol, and serum vitamin A and beta-carotene levels: a case-control study in men. Nutr Cancer 1993 0.82
25 Serum levels of beta-carotene, vitamin A, and zinc in male lung cancer cases and controls. Nutr Cancer 1989 0.79
26 A group therapy approach to facilitate integration of risk information for women at risk for breast cancer. Can J Psychiatry 1998 0.79
27 Two cases of cri-du-chat syndrome with mild phenotypic effect but with different size of 5p deletion. J Paediatr Child Health 1990 0.79
28 Effect of alpha-amyrin palmitate on adjuvant arthritis. Drugs Exp Clin Res 1994 0.78
29 Herbicide use and incidence of neural-tube defects. Lancet 1979 0.77
30 Trisomy 18 at age 21 years. Am J Med Genet 1989 0.76
31 Letter: amniotic alpha-fetoprotein levels and anencephaly. Lancet 1973 0.76
32 Risk of closed lesions in sibs of cases of open neural tube defect. J Med Genet 1977 0.75
33 Prenatal diagnosis and selective abortion for anencephaly and spina bifida. Med J Aust 1974 0.75
34 Maternal serum screening for neural tube defects and Down's syndrome--the NSW perspective. Med J Aust 1991 0.75
35 Letter: Risks of malformed relatives. Lancet 1976 0.75
36 Perceptions and attitudes toward nursing impairment. Res Nurs Health 1987 0.75
37 Bovine congenital arthrogryphosis and hydranencephaly and human neural tube malformations in New South Wales. Aust Vet J 1976 0.75
38 Season of birth in New South Wales. Med J Aust 1979 0.75
39 Spina bifida in South Australia: problems in education. Med J Aust 1971 0.75
40 Mercury in the environment. Med J Aust 1972 0.75
41 Justification of pulse oximeter costs for paramedic prehospital providers. Prehosp Emerg Care 2000 0.75
42 Biochemical differences between amniotic fluid and maternal urine. Br Med J 1977 0.75
43 Recurrent elevations of amniotic fluid alpha-fetoprotein in 3 consecutive normal pregnancies. Aust N Z J Obstet Gynaecol 1982 0.75
44 Investigation of the electrostatic field of the papain active centre by using monoprotonated and diprotonated pyridyl (Py) disulphides as reactivity probes. Biochem Soc Trans 1997 0.75
45 Cerebral malformation in a Manx cat. Vet Rec 1975 0.75
46 Genetic amniocentesis in twin pregnancy. Aust N Z J Obstet Gynaecol 1982 0.75
47 Antipodean 2,4,5-T. Nature 1981 0.75
48 The development of action lines in an Australian maternal serum alphafetoprotein screening service for neural tube defects. Aust N Z J Obstet Gynaecol 1988 0.75
49 Antenatal diagnosis of neural tube defects. Med J Aust 1976 0.75
50 Proceedings: Incidence of anencephalus and spina bifida and variation in risks, according to parental birthplaces in three Australian states. Br J Prev Soc Med 1974 0.75
51 Anencephalus, encephalocele and spinal meningomyelocele. Med J Aust 1974 0.75
52 Letter: Synthetic sex hormones. Med J Aust 1975 0.75
53 Orbital pseudo-pseudotumor in a four-year-old. N Engl J Med 1994 0.75
54 Nuclear number in the rotifer asplanchna: intraclonal variation and environmental control. Science 1966 0.75
55 Letter: Offspring of parents with spina bifida occulta. Lancet 1975 0.75
56 The child with spina bifida: medical and social aspects of the problems of a child with multiple handicaps and his family. Med J Aust 1972 0.75
57 Surveillance of malformations in Sydney in 1976. Med J Aust 1977 0.75